Moderate statin treatment reduces prebeta-1 high-density lipoprotein levels in dyslipidemic patients

Alex G Quinn1, Rachel Schwemberger1, Eveline Oestreicher Stock2

  • 1Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, USA.

Insights

Statin therapy significantly reduces prebeta-1 high-density lipoprotein (HDL), a marker linked to coronary heart disease risk. This reduction is associated with decreased triglycerides, suggesting a beneficial impact on cholesterol efflux.

Area of Science:

  • Cardiovascular Medicine
  • Lipid Metabolism
  • Pharmacology

Background:

  • Elevated prebeta-1 high-density lipoprotein (HDL) is linked to increased atherosclerotic coronary heart disease risk.
  • Prebeta-1 HDL is the primary acceptor of cholesterol effluxed from macrophages.

Purpose of the Study:

  • To evaluate the impact of a 6-week moderate-dose statin treatment on prebeta-1 HDL levels.
  • To understand the relationship between statin therapy, lipid profiles, and prebeta-1 HDL.

Main Methods:

  • 101 patients with hypercholesterolemia or combined hyperlipidemia were treated with statins (mean atorvastatin potency equivalence 23.6 mg/d) for 6 weeks.
  • Prebeta-1 HDL levels were measured using immunofixation of agarose gels with anti-apolipoprotein A-1 antibody before and after treatment.
  • Lipid profiles, including LDL cholesterol and triglycerides, were assessed.

Main Results:

  • Statin treatment resulted in a 42.0% reduction in LDL cholesterol and a 22.3% decrease in triglycerides.
  • Prebeta-1 HDL levels significantly decreased by 17.9% post-treatment (P < .001).
  • The reduction in prebeta-1 HDL was strongly correlated with triglyceride reduction, not LDL cholesterol reduction.

Conclusions:

  • Statin therapy effectively reduces prebeta-1 HDL levels, a marker associated with coronary heart disease.
  • The observed reduction in prebeta-1 HDL may be partly due to decreased triglycerides and potentially a direct beneficial effect on cholesterol efflux.
  • These findings highlight a potential mechanism for statins' cardioprotective effects beyond LDL reduction.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
520
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
773
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
711
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.8K
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
2.4K